Abstract
The plant alkaloids ryanodine and dehydroryanodine are high affinity, biphasic modulators of the intracellularly located, calcium-regulated calcium release channels of a variety of cell types. To date, little is certain about the molecular basis of the interactions that prompt low concentrations of ryanodine (nanomolar to low micromolar) to activate (open) the channels and higher concentrations to deactivate (functionally close) the sarcoplasmic reticulum calcium release channel. In the present study, we approached this question using novel, semi-synthetic C10−Oeq ester derivatives of ryanodine and dehydroryanodine as molecular probes of the ryanodine binding sites on the calcium release channel.
Binding affinities of these C10−Oeq ester derivatives of ryanodine and dehydroryanodine with acidic, basic and neutral side chains (Kd values> 53.9 nM, Kd values 0.3–0.7 nM and Kd values 1.3–20.4 nM, compared with 2.3 and 2.8 nM for ryanodine and dehydroryanodine, respectively) were evaluated for their ability to modulate, the patency of the sarcoplasmic reticulum calcium release channel. With the exception of only two derivatives tested to date, all the semi-synthetic C10−Oeq esters selectivelyactivate the Ca2+ release channel. That is, they produce no functional closure of the sarcoplasmic reticulum calcium release channels at the highest concentration, that could be tested. Half-maximal concentrations for activation (EC50act , values) ranged from 0.87–4.2, μM, compared with an EC50act of 1.3 μM for ryanodine.
Using a low concentration (0.5 nM) of a high specific activity, radioiodinated derivative of ryanodine, C10−Oeq N-(4-azido-5-125iodo salicyloyl) glycyl ryanodine (1400 Ci/mmol) as the radioligand in displacement binding affinity assays, two distinct, sequential ryanodine binding isotherms were demonstrated within the normal 0–300 nM ryanodine sigmoidal displacement curve. A high affinity site had an IC50 of 0.5 nM (Kd=0.26±0.02 nM). Above this concentration, an apparent plateau occurred between 3 and 6 nM ryanodine, and at higher concentrations a lower affinity site, was revealed that demonstrated an IC50 of about 25 nM (Kd=11.7±1.2, nM). Scatchard analysis from direct binding of C10−Oeq N-(4-azido-5-125iodo salicyloyl) glycyl ryanodine to junctional sarcoplasmic reticulum vesicles also suggests the presence of more than one class of binding sites within the nanomolar concentration range. The high affinity site, demonstrated a Bmax of 3 pmol/mg protein. We were unable to saturate the lower affinity binding sites with this ligand.
To evaluate the functional effects occurring among sarcoplasmic reticulum calcium release channel monomers as a consequence of ryanodine's binding, we utilized a photo-activatable derivative of ryanodine, C10−Oeq N-(4-azido salicyloyl) glycyl ryanodine that demonstrates channel modulating characteristics similar to ryanodine. Covalently labeling the sarcoplasmic reticulum calcium-release channels with this ligand, followed by measurements of rates of calcium efflux and SDS-PAGE of the labeled protein, revealed that deactivation of the sarcoplasmic reticulum calcium release channels of skeletal muscle by this ryanoid occurred at concentrations which apparently produce virtually irreversibly, interactions between receptor monomers. This ‘polymerization’ was indicated by the progressive appearance of two higher molecular weight protein bands on SDS-PAGE concomitant with progressive decreases in the ryanodine receptor monomer band that runs at an apparent molecular mass of 365 kDa.
In summary, we have prepared an utilized, novel C10−Oeq ester derivatives of ryanodine and dehydroryanodine in studies aimed at better understanding the molecular basis for the complex biphasic actions of ryanodine on the sarcoplasmic reticulum calcium release channels from rabbit skeletal muscle cells. The described studies presage correlations that may be useful in furthering our understanding of structure-function relationship among ryanoids.
Similar content being viewed by others
References
Ebashi I, Endo M: Calcium and muscle contraction. Prog Biophys Mol Biol 18: 123–183, 1968
Inesi G: Active transport of calcium ion in sarcoplasmic membrane. Ann Rev Biophys Bioeng 1: 191–210, 1972
Endo M: Calcium release from the sarcoplasmic reticulum Physiol Rev 57: 561–573, 1977
Tada M, Yamamoto T, Tonomura Y: Molecular mechanism of active calcium transport by sarcoplasmic reticulum. Physiol Rev 58: 1–79, 1978
Inesi G: Mechanism of calcium transport. Ann Rev Physiol 47: 573–601, 1985
Pozzan T, Rizzuto R, Volpe P, Meldolesi J: Molecular and cellular physiology of intracellular calcium stores. Physiol Rev, 74: 595–636, 1994
Jenden DJ, Fairhurst AS: The pharmacology of ryanodine. Pharmacol Rev 21: 1–25, 1969
Sutko JL, Willerson JT: Ryanodine alteration of the contractile state of rat ventricular myocardium, comparison with dog, cat and rabbit ventricular tissues. Circ Res 46: 332–343 1980
Fleischer S, Ogunbunmi EM, Dixon MC, Fleer EA: Localization of Ca2+ release channels with ryanodine in junctional terminal wisternae of sarcoplasmic reticulum of fast skeletal muscle. Proc Natl Acad Sci (USA) 82: 7256–7259, 1985
Hisayama T, Takayanagi I: Ryanodine: its possible mechanism of action in the caffeine-sensitive calcium stores of smooth muscle. Pfluger's Archiv 412: 376–381, 1988
Tekemura H, Hughes AR, Thastrup O, Putney JW Jr: Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. J Biol Chem 264: 12266–12271, 1989
Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP: Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci (USA) 87: 2466–2470, 1990
Damaurex N, Lew DP, Krause K-H: Cyclopiazonic acid depletes intracellular Ca2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J. Biol Chem 267: 2318–2324, 1992
Suzuki M, Maraki K, Imaizumi Y, Watanabe M: Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca2+-pump, produces Ca2+-dependent K+ currents in guinea-pig smooth muscle cells. Brit J Pharmacol 107: 134–137, 1992
Waterhouse AL, Pessah I, Francini AO, Casida JE: Structural aspects of ryanodine action and selectivity. J Med Chem, 30: 710–716, 1987
Jefferies PR, Toia RF, Brannigan B, Pessah I, Casida JE: Ryania insecticide: analysis and biological activity of 10 natural ryanoids. J Agric Food Chem 40: 142–146, 1992
Jefferies PR, Lehmberg E, Lam W-W, Casida JE: Bioactive ryanoids from nuclophilic addition to 4,12 seco-4, 12-dioxoryanodine. J Med Chem 36: 1128–1136, 1993
Gerzon K, Humerickhouse RA, Besch HR Jr, Bidasee KR, Emmick JT, Roeske RW, Tian Z, Ruest L, Sutko JL: Amino-and guanidinoacyl ryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum Ca2+-release channel. J Med Chem 36: 1319–1323, 1993
Welch W, Ahamad S, Airey JA, Gerzon K, Humerickhouse RA, Besch HR Jr, Ruest L, Sutko JL: Structural determinants of high-affinity binding of ryanoids to the, vertebrate skeletal muscle ryanodine receptor: a comparative molecular field analysis. Biochem 33: 6074–6085, 1994
Humerickhouse RA, Besch HR Jr, Gerzon K, Ruest L, Sutko JL, Emmick JT: Differential activating and deactivating effects of natural ryanodine congeners on the calcium release channel of sarcoplasmic reticulum: evidence for separation of effects at functionally distinct sites. Mol Pharmacol 44: 412–421, 1993
Humerickhouse RA, Bidasee KR, Gerzon K, Emmick JT, Kwon S, Sutko JL, Ruest L, Besch HR Jr: High affinity C10−Oeq ester derivatives of ryanodine: activator-selective agonist of the sarcoplasmic reticulum calcium release channel. J Biol Chem 269: 30243–30253, 1994
Meissner G: Ryanodine activation and inhibition of the Ca2+-release channel of sarcoplasmic reticulum. J Biol Chem 261: 6300–6306, 1986
Lattanzio FA, Schlatterer RG, Nicar M, Campbell K, Sutko JL: The effect of ryanodine on passive calcium fluxes across sarcoplasmic reticulum membranes. J Biol Chem 262 2711–2718, 1987
Bidasee KR, Besch HR Jr, Kwon S, Emmick JT, Besch KT, Gerzon K, Humerickhouse, RA: C10−Oeq N-(4-azido-5125iodo salicyloyl)-β-alanyl-β-alanyl ryanodine (Az-βAR), a novel photo-affinity ligand for the ryanodine binding site. J Labelled Comp Radiopharm 34: 33–47, 1994
Lowry OH, Roseborough NJ, Farr AL, Randall RJ: Protein measurement with the Folinphenol reagent. J Biol Chem 193: 2265–2275, 1951
Sutko JL, Thompson LJ, Schlatterer RG, Lattanzio FA, Fairhurst AS, Campbell K, Martin SF, Deslongchamps P, Ruest L, Taylor DR: Separation and formation of ryanodine from dehydroryanodine: preparation of tritium-labeled ryanodine. J Labelled Comp Radiopharm 23: 215–222, 1986
Neisses B, Steglich W: Simple method for the esterification of carboxylic acids. Angew Chem Int Ed Eng, 17: 522–525, 1978
Halushka PV, MacDermot J, Knapp DR, Eller T, Saussy DL Jr, Mais D, Blair IA, Dollery CT: A novel, approach for the study of thromboxane A2 and prostaglandin H2 receptors using an125I-labeled ligand. Biochem Pharmacol 34: 1165–1170, 1985
Besch HR Jr, Bidasee KR, Kwon S, Humerickhouse RA Emmick JT: Ryanoid binding isotherm has two distinct components. Biophys J 66: A418, 1994
Kwon S, Bidasee KR, Besch HR Jr, Humerickhouse RA, Emmick JT: Correlation of ryanodine's binding with its intrinsic activity on the sarcoplasmic reticulum calcium-release channel. Biophys J 66: A419, 1994
Bidasee KR, Besch HR Jr, Kwon S, Emmick JT, Gerzon K, Humerickhouse RA, Besch KT: Photoaffinity labeling of the ryanodine receptor: Quantitation of the relationship between receptor occupancy and biphasic actions on sarcoplasmic reticulum calcium release channels. Manuscript in preparation.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Bidasee KR, Kwon S, Besch HR Jr, Humerickhouse RA, Emmick JT: Deactivation of the SR calcium-release channel reflects crosslinking among monomers. Biophys J 66: A419, 1994
Jayaraman T, Brillantes A, Timerman AP, Fleischer S, Erdjument-Bromage H, Tempst P, Marks AR: FK506 binding protein associated with the calcium release channel (ryanodine receptor) J BiolChem 267: 9474–9477, 1992
Wang JP, Needleman DH, Hamilton SL: Relationship of low affinity [3H] ryanodine binding sites to high affinity sites on skeletal muscle Ca2+ release channel. J BiolChem, 268: 20974–20982, 1993
Tinker A, Sutko JL, Ruest L, Welch W, Airey J, Gerzon K, Bidasee KR, Besch HR Jr, Williams AJ: The electrophysiological effects of ryanodine derivatives on the sheep cardiac sarcoplasmic reticulum Ca2+-release channel. Biophys J 66: A315, 1994
Motoike HK, Caswell AH, Smilowitz HM, Brandt NR: Extraction of junctional complexes from triad junctional of rabbit skeletal muscle. J Muscle Res Cell Motil 15: 493–504, 1994
Author information
Authors and Affiliations
Additional information
This work was supported in part by the Showalter Trust.
Rights and permissions
About this article
Cite this article
Bidasee, K.R., Besch, H.R., Gerzon, K. et al. Activation and deactivation of sarcoplasmic reticulum calcium release channels: Molecular dissection of mechanisms via novel semi-synthetic ryanoids. Mol Cell Biochem 149, 145–160 (1995). https://doi.org/10.1007/BF01076573
Issue Date:
DOI: https://doi.org/10.1007/BF01076573